Heartburn, reflux, burping and gas are labeled adverse reactions for several GLP-1 and dual-agonist medications. For Zepbound (tirzepatide), trial data lists dyspepsia (~6%), eructation/burping (~4%), gastroesophageal reflux disease (~3%) and flatulence (~2%). Wegovy's (semaglutide) labeling similarly includes dyspepsia, abdominal distension, eructation, flatulence and GERD among its common (≥5% grouped) reactions. The underlying reason is delayed gastric emptying, a core, intended effect of these drugs that also means food and gas linger longer in the stomach. Smaller, lower-fat meals, eating slowly, avoiding lying down right after eating, and limiting carbonated drinks are the main practical steps that help. Severe or persistent abdominal pain, especially radiating to the back, vomiting that won't stop, or signs of gallbladder trouble are red flags that need medical attention, not something to manage with diet alone.
Key takeaways
- Heartburn (GERD), dyspepsia, burping and gas are labeled, common GLP-1 adverse reactions, not unrelated coincidences.
- The core mechanism is delayed gastric emptying, an intended pharmacologic effect of GLP-1 and dual GIP/GLP-1 medications.
- Meal size, fat content, eating pace and posture after eating are the biggest levers most people can adjust.
- Red flag: severe abdominal pain radiating to the back, persistent vomiting, or signs of gallbladder disease need prompt medical evaluation.
Are heartburn, reflux and gas actually listed GLP-1 side effects?
Yes, and the FDA prescribing information is specific about it. For Zepbound (tirzepatide), the labeled adverse reactions include dyspepsia in about 6% of patients, eructation (burping) in about 4%, gastroesophageal reflux disease in about 3%, and flatulence and abdominal distension each in about 2%. These are grouped with the more widely known reactions like nausea (20%), diarrhea (15%) and vomiting (11%) as part of the drug's overall gastrointestinal profile.
Wegovy's (semaglutide) prescribing information lists dyspepsia, abdominal pain, abdominal distension, eructation, flatulence and gastroesophageal reflux disease among the adverse reactions occurring in ≥5% of patients when grouped with the broader GI reaction list, alongside nausea, vomiting, constipation and headache. In both drugs' trial programs, gastrointestinal reactions were also the leading reason people stopped treatment, underscoring that this cluster of symptoms is a genuine, non-trivial part of the side-effect profile, not background noise.
Why does delayed gastric emptying cause this?
GLP-1 receptor agonists, and the dual GIP/GLP-1 agonist tirzepatide, work partly by slowing how quickly food moves out of the stomach. That's a deliberate part of the mechanism: it extends fullness and reduces appetite. The tradeoff is that food, stomach acid, and swallowed air all sit in the stomach longer than usual.
- Heartburn and reflux (GERD) can result when a fuller, slower-emptying stomach makes it easier for acid to move back up into the esophagus, particularly after larger or fattier meals, or when lying down soon after eating.
- Dyspepsia (a general term for upper-abdominal discomfort, bloating or early fullness after eating) reflects the same slowed digestion.
- Burping and gas increase as food and air linger and ferment longer than they would with normal-speed digestion, similar to the mechanism behind the "sulfur burps" some people report; see our dedicated guide to sulfur burps for more on that specific symptom.
These effects tend to be most noticeable early in treatment and after each dose increase, then often ease somewhat as the body adjusts, mirroring the broader pattern seen with GLP-1 GI side effects generally.
What may help
None of the following replaces medical advice, but these are the practical, non-prescriptive steps that address the underlying mechanism:
- Eat smaller meals. A fuller stomach has more capacity to reflux; smaller portions reduce that pressure.
- Cut back on fat and grease. Fatty foods slow gastric emptying even further on top of the drug's own effect, compounding reflux and dyspepsia.
- Eat slowly and stop before you're overly full. Rushed, large meals swallow more air and stretch the stomach more, both of which feed burping and reflux.
- Don't lie down right after eating. Staying upright for a couple of hours after a meal reduces the chance of acid moving backward.
- Limit carbonated drinks if gas or burping is bothersome; the added gas has nowhere to go quickly with slower digestion.
- Stay hydrated with plain water between meals rather than large volumes with meals, which can add to stomach fullness.
- Ask your clinician or pharmacist about over-the-counter options for frequent heartburn, since some antacid or acid-reducing products interact with other medications or conditions.
If nausea is part of your picture too, our guide on stopping GLP-1 nausea covers overlapping meal-timing and food-choice strategies.
| Symptom | Likely mechanism | What may help |
|---|---|---|
| Heartburn / reflux (GERD) | Fuller stomach, delayed emptying, pressure on the esophageal sphincter | Smaller, lower-fat meals; stay upright after eating |
| Dyspepsia (upper-abdomen discomfort, early fullness) | Slowed digestion, stomach distension | Smaller portions; eat slowly; avoid very rich meals |
| Burping (eructation) | Swallowed air and gas lingering longer in a slower-emptying stomach | Eat slowly; limit carbonated drinks |
| Gas / bloating (flatulence, distension) | Food fermenting longer before it moves on | Smaller meals; gradual fiber changes; movement after eating |
When these symptoms are a warning sign
Ordinary reflux, gas and dyspepsia are uncomfortable but generally self-limited. Some presentations need medical attention rather than home management:
- Severe or persistent abdominal pain, especially pain that radiates to the back, which can be a sign of pancreatitis. See our guide on who should not take a GLP-1 for more on this warning.
- Vomiting that won't stop or an inability to keep fluids down, which raises the risk of dehydration and can signal a more serious problem.
- Chest pain, which should always be evaluated urgently rather than assumed to be heartburn.
- Signs suggesting gallbladder disease, such as right-upper-abdominal pain with fever, nausea, or yellowing of the skin or eyes.
- Symptoms that steadily worsen instead of following the usual early-adjustment pattern.
For the complete picture of what's typical versus concerning, see our full GLP-1 side-effects guide.
Frequently asked questions
Can GLP-1 drugs cause heartburn?
Yes. Gastroesophageal reflux disease (GERD), dyspepsia (indigestion/heartburn-type discomfort), burping and gas are listed as adverse reactions in FDA prescribing information for GLP-1 and dual-agonist medications, most commonly linked to delayed gastric emptying.
Why do I have gas or burps on a GLP-1?
These drugs slow how quickly the stomach empties. Food and swallowed air sit longer, which can produce more burping, bloating and gas, especially with larger, fattier, or carbonated-drink-heavy meals.
What helps reflux on a GLP-1?
Smaller, lower-fat meals, eating slowly, not lying down right after eating, limiting carbonated drinks and known trigger foods, and staying hydrated are the main practical steps. Ask your clinician or pharmacist about over-the-counter options if symptoms are frequent.
When should I call a clinician about GLP-1 heartburn or gas?
Contact a clinician or seek urgent care for severe or persistent abdominal pain (especially pain radiating to the back), vomiting that won't stop, inability to keep fluids down, chest pain, or symptoms suggesting gallbladder problems such as pain with fever or yellowing skin.
Sources & further reading
- U.S. Food & Drug Administration, prescribing information for Zepbound (tirzepatide) injection.
- U.S. Food & Drug Administration, prescribing information for Wegovy (semaglutide) injection.
- U.S. Food & Drug Administration, prescribing information for Ozempic (semaglutide) injection.